Gut Microbiome and p-Inulin in Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 24, 2017

Study Completion Date

January 31, 2019

Conditions
End-Stage Renal DiseaseGut Microbiome Dysbiosis
Interventions
DIETARY_SUPPLEMENT

p-inulin

12 week self-administered treatment phase

Trial Locations (4)

20037

The George Washington University, Washington D.C.

37232

Vanderbilt University Medical Center, Nashville

98104

Kidney Research Institute, University of Washington, Seattle

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Brigham and Women's Hospital

OTHER

collaborator

George Washington University

OTHER

collaborator

Vanderbilt University

OTHER

collaborator

University of Washington

OTHER

lead

University of Pennsylvania

OTHER

NCT02572882 - Gut Microbiome and p-Inulin in Hemodialysis | Biotech Hunter | Biotech Hunter